Sanofi voted ‘Leading Pan-European Quoted Company for Investor Relations’
It has also been voted first in the European pharmaceuticals and biotechnology sector as well as first among CAC 40 companies
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Sanofi announces results of ORIGIN trial on diabetes
The six-year randomised clinical trial was designed to assess the effects of treatment with insulin glargine versus standard care…
DuBiotech to sign MoU with IDMA
Offers slew of incentives for Indian pharma companies Dubai’s DuBiotech (Dubai Biotechnology and Research Park), one of the top…
Image Core Lab, Teleradiology Solutions and DIA to conduct workshop on imaging in clinical trials
Speakers will review the current practice of imaging biomarkers in clinical trials Image Core Lab in collaboration with…
Piramal Imaging presents data on molecular imaging portfolio
Research from more than a dozen studies across multiple compounds were presented Piramal Imaging, a subsidiary of Piramal…
Venus Remedies wins US patent for drug to fight resistant `superbugs’
This novel antibiotic adjuvant entity has been found effective against even the toughest carbapenemase resistant…
Harold Hamm Diabetes Centre announces award for biomedical research in diabetes
HHDC will award and administer the $250,000 prize With a goal of stimulating innovative scientific research to find a cure for…
DIA India Workshop drives IP innovation and collaboration home
Various dimensions of licensing associated with IP protection were discussed among other issues With the issue of patents in the…
Novartis drug Gilenya shows long-term efficacy and safety
Basel New long-term data for Gilenya (fingolimod), the only oral therapy approved to treat people with relapsing forms of…
Piramal Healthcare acquires Decision Resources Group
Completes acquisition for approximately Rs 3,400 crore Piramal Healthcare has completed its previously announced acquisition of…